Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Results vary depending on individual factors such as starting weight, adherence to the program, and overall health, particularly in those who are overweight or obese
In 2024, Wegovy received an additional FDA approval saying it can help reduce the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and living with either obesity or overweight
Nausea is the most commonly reported adverse effect
People with diabetes, kidney disease, liver disease, eating-disorder history, or who are pregnant or breastfeeding should consult a registered dietitian or physician before changing macro ratios substantially
US$ 21.71
US$ 23.13
US$ 23.62
